Abstract
Skin cancer is a common and potentially fatal disease where early detection can save lives, especially for melanoma. Current deep learning systems classify skin lesions well, but they mainly rely on appearance cues and may miss deeper structural patterns in lesions. We present TopoCon MP, a method that extracts multiparameter topological signatures from dermoscopic images to capture multiscale lesion structure, and fuses these signatures with Vision Transformers using a supervised contrastive objective. Across three public datasets, TopoCon MP consistently improves performance over strong pretrained CNN and ViT baselines, including in cross dataset transfer. Ablations show that multiparameter topology and contrastive fusion each contribute to the gains. The resulting topological channels also provide an interpretable view of lesion organization, aligning with clinically meaningful structures. Overall, TopoCon MP demonstrates that multipersistence based topology can serve as a complementary modality for robust skin cancer detection.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was partially supported by National Science Foundation under grants DMS-2220613, and DMS-2229417.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
https://medmnist.com/ https://challenge.isic-archive.com/landing/milk10k/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
ftastan{at}ucsc.edu, sayoni.chakraborty{at}utdallas.edu, sangyeon.lee{at}utdallas.edu, coskunuz{at}utdallas.edu
Data Availability
All data produced are available online at https://medmnist.com/ and https://challenge.isic-archive.com/landing/milk10k/
